Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172210 | SCV000051277 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000152193 | SCV000200939 | uncertain significance | not specified | 2014-12-04 | criteria provided, single submitter | clinical testing | The p.Arg27105Gln variant in TTN has not been previously reported in individuals with cardiomyopathy, but has been identified in 3/8262 European American chromo somes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs200639218). Computational prediction tools and conservation analysis sug gest that this variant may impact the protein, though this information is not pr edictive enough to determine pathogenicity. In summary, the clinical significanc e of the p.Arg27105Gln variant is uncertain. |
Invitae | RCV000532604 | SCV000643858 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-07-25 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000172210 | SCV000855249 | uncertain significance | not provided | 2018-02-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765549 | SCV000896864 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000172210 | SCV001780053 | likely benign | not provided | 2019-06-24 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000172210 | SCV003826720 | uncertain significance | not provided | 2023-12-07 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149922 | SCV003837961 | benign | Cardiomyopathy | 2022-02-16 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000172210 | SCV001550582 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The TTN p.Arg27105Gln variant was not identified in the literature but was identified in dbSNP (ID: rs200639218) and ClinVar (classified as uncertain signifcance by Invitae, Laboratory for Molecular Medicine, Fulgent Genetics, EGL Genetics and Biesecker Lab/Clinical Genomics Section, National Institutes of Health). The variant was identified in control databases in 60 of 279880 chromosomes at a frequency of 0.0002144 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Latino in 29 of 35362 chromosomes (freq: 0.00082), Other in 2 of 7114 chromosomes (freq: 0.000281), South Asian in 8 of 30600 chromosomes (freq: 0.000261), European (non-Finnish) in 19 of 127734 chromosomes (freq: 0.000149), Ashkenazi Jewish in 1 of 10334 chromosomes (freq: 0.000097) and East Asian in 1 of 19526 chromosomes (freq: 0.000051), but was not observed in the African or European (Finnish) populations. The p.Arg27105 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. | |
Laboratory of Diagnostic Genome Analysis, |
RCV000172210 | SCV001799187 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000172210 | SCV001923788 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000172210 | SCV001972516 | uncertain significance | not provided | no assertion criteria provided | clinical testing |